Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

It’s the 500-lb gorilla of electronic prescribing, and you’ll want to know it backwards and forwards. It’s NCPDP Script 2017071, and APC’s new live webinar, E-Prescribing in Compounding, will help you do just that.

Taught by pharmacy compounding technology expert (and CEO of ElectricLab Software) Michelle Wong, PharmD, E-Prescribing in Compounding will teach you why 2017071 applies to you, how to use it best, and how it can help you collaborate with prescribers to enhance continuity of care.

E-Prescribing in Compounding is Tuesday, December 15, from 2:00–3:00pm EST. A mere $55 for APC pharmacist members; $30 for students or techs. Non-members pay $75. Gives 1 hour of ACPE-accredited CE.

Go to A4PC.org/escripts to register today!